Exercise PH — measured by the mPAP/CO slope — may predict survival in patients with normal or mildly elevated pulmonary arterial pressure.

Abstract: Numerical models with varying degrees of complexity are widely employed for investigating the intricate hemodynamics associated with pathological conditions such as ischemic stroke. To ...

The Food and Drug Administration (FDA) gave the green light to the the first-ever medication for obstructive sleep apnea (OSA). The newly approved drug, Zepbound (tirzepatide), targets adults with ...

The U.S. Food and Drug Administration (FDA) has granted approval for Zepbound, a weight-loss medication, to treat moderate to severe obstructive sleep apnea (OSA) in individuals with obesity.

Objective To compare the effectiveness and safety of budesonide-glycopyrrolate-formoterol, a twice daily metered dose inhaler, and fluticasone-umeclidinium-vilanterol, a once daily dry powder inhaler, ...

Systolic blood pressure <90 mm Hg for 30 minutes before inotropes/vasopressors, or vasopressors or IABP are required to maintain systolic blood pressure ≥90 mm Hg ...

Manchester United's chances of signing Dani Olmo on a free transfer from Barcelona could receive a significant boost on Friday, according to reports in Spain. Olmo's future has been the subject of ...

Breathing-related sleep disorders, particularly obstructive sleep apnea ... events that occur during sleep lead to acute and chronic hemodynamic changes during wake time, including elevated ...

Although the structural changes in CPA can be characterized using standard radiologic modalities, assessing the vascular hemodynamics in patients with CPA remains challenging due to inadequate imaging ...

The first medication for obstructive sleep apnea has been approved by the US Food and Drug Administration (FDA). On Dec. 20, the FDA announced that the agency has approved Eli Lilly’s Zepbound ...